Host immunity contributes to the anti-melanoma activity of BRAF inhibitors

Deborah A. Knight(Peter MacCallum Cancer Centre), Mark J. Smyth(The University of Queensland)

Journal of Clinical Investigation

February 1, 2013

10.1172/jci66236

Cited by 270

Related Papers

Immune surveillance of tumors

|Journal of Clinical Investigation|2007|1.4k

Sequential production of interferon-γ by NK1.1+ T cells and natural killer cells is essential for the antimetastatic effect of α-galactosylceramide

|Blood|2002|383

IFN-γ is required for cytotoxic T cell-dependent cancer genome immunoediting

|Nature Communications|2017|146

DNAM-1 Expression Marks an Alternative Program of NK Cell Maturation

|Cell Reports|2015|125

NK cell heparanase controls tumor invasion and immune surveillance

|Journal of Clinical Investigation|2017|101